Funding
ONCOLOGY
FS received a European Society for Medical Oncology (ESMO) Fellowship – Translational and the 2021 BBVA Foundation/Hospital Clinic of Barcelona Joan Rodés—Jose Baselga Advanced Research Contract in Oncology. Any views, opinions, findings, conclusions, or recommendations expressed in this material are those solely of the author and do not necessarily reflect those of Funding Entities. The OLTRE trial was conducted with Astra-Zeneca contribution providing olaparib. The funder had no role in the design of the study nor of its collateral sub-analyses; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. This research was also supported by Mednote, spin-off—University of Trieste—Mozart Program.